StonvexLoading…
StonvexStonvexStonvexCore line items from ALIT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $506.95M | $534.00M | $2.26B | $1.61B | $1.08B |
Operating Income | Not available | $-22.00M | $-3.09B | $-2.34B | $-1.02B |
Net Income | Not available | $-19.00M | $-3.10B | $-2.17B | $-1.10B |
EPS (Diluted) | $0.04 | $-0.04 | $-5.87 | $-4.09 | $-2.07 |
Total Assets | Not available | $4.34B | $4.57B | $5.54B | $6.78B |
Total Liabilities | Not available | $3.31B | $3.52B | $3.53B | $3.66B |
Cash & Equivalents | Not available | $178.00M | $273.00M | $205.00M | $227.00M |
Free Cash Flow OCF − CapEx | Not available | $53.00M | $250.00M | $151.00M | $102.00M |
Shares Outstanding | Not available | 524.74M | 527.57M | 529.21M | 530.38M |